share_log

Lumentum Holdings Analyst Ratings

Benzinga ·  Nov 9, 2023 07:37
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/09/2023 25.96% Raymond James $49.5 → $54 Maintains Outperform
10/31/2023 28.29% Rosenblatt $62 → $55 Maintains Buy
10/31/2023 15.47% Raymond James $51.5 → $49.5 Maintains Outperform
10/27/2023 4.97% Morgan Stanley $55 → $45 Maintains Equal-Weight
10/24/2023 4.97% Susquehanna $55 → $45 Maintains Positive
10/10/2023 4.97% B of A Securities $50 → $45 Maintains Underperform
08/18/2023 23.63% Craig-Hallum $50 → $53 Maintains Hold
08/18/2023 4.97% B. Riley Securities $46 → $45 Maintains Neutral
08/18/2023 28.29% Stifel $62 → $55 Maintains Buy
08/18/2023 32.96% JP Morgan $64 → $57 Maintains Overweight
08/18/2023 14.3% UBS $48 → $49 Maintains Neutral
08/18/2023 20.13% Raymond James $64 → $51.5 Maintains Outperform
08/18/2023 44.62% Rosenblatt $67 → $62 Upgrades Neutral → Buy
08/18/2023 37.63% Needham → $59 Reiterates Buy → Buy
07/25/2023 39.96% Susquehanna $55 → $60 Maintains Positive
07/18/2023 16.63% B of A Securities → $50 Downgrades Neutral → Underperform
07/05/2023 -2.03% Barclays $40 → $42 Downgrades Equal-Weight → Underweight
06/21/2023 56.29% Rosenblatt $48 → $67 Maintains Neutral
06/13/2023 28.29% Susquehanna → $55 Reiterates Positive → Positive
05/10/2023 28.29% Loop Capital $78 → $55 Maintains Buy
05/10/2023 49.29% Raymond James $73 → $64 Maintains Outperform
05/10/2023 28.29% Morgan Stanley $60 → $55 Maintains Equal-Weight
05/10/2023 11.97% Rosenblatt → $48 Reiterates → Neutral
05/10/2023 -6.69% Barclays $55 → $40 Downgrades Overweight → Equal-Weight
05/10/2023 37.63% Needham → $59 Reiterates → Buy
04/25/2023 28.29% Susquehanna $70 → $55 Maintains Positive
04/18/2023 -6.69% Northland Capital Markets $57 → $40 Maintains Market Perform
04/17/2023 39.96% JP Morgan $54 → $60 Upgrades Neutral → Overweight
04/06/2023 70.28% Raymond James $84 → $73 Maintains Outperform
04/06/2023 39.96% Morgan Stanley $66 → $60 Maintains Equal-Weight
04/06/2023 16.63% UBS $59 → $50 Maintains Neutral
04/06/2023 16.63% Craig-Hallum → $50 Downgrades Buy → Hold
04/06/2023 28.29% Barclays $65 → $55 Maintains Overweight
04/06/2023 37.63% Needham $72 → $59 Maintains Buy
04/06/2023 11.97% Rosenblatt $77 → $48 Downgrades Buy → Neutral
03/09/2023 63.28% Susquehanna → $70 Reiterates → Positive
02/10/2023 63.28% Susquehanna $85 → $70 Maintains Positive
02/10/2023 32.96% Northland Capital Markets $65 → $57 Maintains Market Perform
02/10/2023 51.62% Barclays $70 → $65 Maintains Overweight
02/10/2023 53.95% B. Riley Securities $90 → $66 Downgrades Buy → Neutral
02/10/2023 95.94% Raymond James $85 → $84 Maintains Outperform
02/10/2023 67.95% Needham → $72 Reiterates → Buy
01/18/2023 72.61% Rosenblatt $80 → $74 Maintains Buy
12/20/2022 49.29% JP Morgan $83 → $64 Downgrades Overweight → Neutral
12/13/2022 UBS Initiates Coverage On → Neutral
12/13/2022 53.95% Morgan Stanley $75 → $66 Maintains Equal-Weight
12/02/2022 58.62% Stifel → $68 Initiates Coverage On → Buy
11/11/2022 44.62% B of A Securities $84 → $62 Downgrades Buy → Neutral
11/09/2022 74.95% Morgan Stanley $84 → $75 Maintains Equal-Weight
11/09/2022 51.62% Northland Capital Markets $120 → $65 Downgrades Outperform → Market Perform
11/09/2022 86.61% Rosenblatt $125 → $80 Maintains Buy
11/09/2022 98.27% Raymond James $107 → $85 Maintains Outperform
11/09/2022 67.95% Needham $125 → $72 Maintains Buy
10/24/2022 86.61% Barclays $95 → $80 Maintains Overweight
10/19/2022 149.59% Raymond James $114 → $107 Maintains Outperform
10/11/2022 95.94% Morgan Stanley $98 → $84 Maintains Equal-Weight
09/06/2022 144.93% B of A Securities → $105 Initiates Coverage On → Buy
08/17/2022 128.6% Morgan Stanley $94 → $98 Maintains Equal-Weight
08/17/2022 165.92% Raymond James $102 → $114 Maintains Outperform
08/04/2022 137.93% Raymond James $118 → $102 Maintains Outperform
07/25/2022 121.6% Barclays $100 → $95 Maintains Overweight
07/14/2022 133.26% JP Morgan $115 → $100 Maintains Overweight
05/05/2022 156.59% Susquehanna $120 → $110 Maintains Positive
05/05/2022 175.25% Raymond James $114 → $118 Maintains Outperform
05/02/2022 119.27% Morgan Stanley $97 → $94 Maintains Equal-Weight
04/25/2022 133.26% Barclays $105 → $100 Maintains Overweight
04/14/2022 168.25% Craig-Hallum $130 → $115 Maintains Buy
03/24/2022 191.58% Rosenblatt $115 → $125 Maintains Buy
03/15/2022 165.92% Raymond James $99 → $114 Maintains Outperform
03/09/2022 179.92% Northland Capital Markets $110 → $120 Maintains Outperform
02/04/2022 126.27% Morgan Stanley $91 → $97 Maintains Equal-Weight
02/04/2022 168.25% Rosenblatt $105 → $115 Maintains Buy
02/04/2022 130.93% Raymond James $96 → $99 Maintains Outperform
01/26/2022 156.59% JP Morgan → $110 Upgrades Neutral → Overweight
01/20/2022 156.59% JP Morgan $100 → $110 Maintains Neutral
12/15/2021 179.92% Susquehanna $100 → $120 Maintains Positive
12/13/2021 133.26% JP Morgan $95 → $100 Maintains Neutral
11/05/2021 133.26% Barclays $90 → $100 Maintains Overweight
11/05/2021 112.27% Morgan Stanley $81 → $91 Maintains Equal-Weight
11/05/2021 144.93% Rosenblatt $85 → $105 Upgrades Neutral → Buy
10/12/2021 Raymond James Downgrades Strong Buy → Outperform
08/19/2021 133.26% Craig-Hallum $90 → $100 Maintains Buy
08/19/2021 98.27% Rosenblatt $80 → $85 Maintains Neutral
08/19/2021 123.93% Raymond James $85 → $96 Maintains Strong Buy
07/19/2021 133.26% Needham $87 → $100 Maintains Buy
06/01/2021 100.61% Goldman Sachs $104 → $86 Downgrades Buy → Neutral
05/18/2021 98.27% Raymond James $93 → $85 Maintains Strong Buy
05/14/2021 86.61% JP Morgan $118 → $80 Downgrades Overweight → Neutral
05/13/2021 109.94% Susquehanna $120 → $90 Maintains Positive
05/13/2021 109.94% Northland Capital Markets $130 → $90 Maintains Outperform
05/13/2021 158.92% B. Riley Securities $126 → $111 Maintains Buy
05/13/2021 109.94% Craig-Hallum $120 → $90 Maintains Buy
05/13/2021 100.61% MKM Partners $116 → $86 Maintains Buy
05/13/2021 86.61% Rosenblatt $97 → $80 Maintains Neutral
05/13/2021 88.94% Morgan Stanley → $81 Downgrades Overweight → Equal-Weight
05/13/2021 102.94% Needham $123 → $87 Maintains Buy
03/26/2021 161.25% Raymond James → $112 Upgrades Outperform → Strong Buy
03/25/2021 186.91% Needham $120 → $123 Maintains Buy
03/18/2021 126.27% Rosenblatt $105 → $97 Downgrades Buy → Neutral
02/03/2021 161.25% Raymond James $108 → $112 Maintains Outperform
02/03/2021 179.92% Needham $115 → $120 Maintains Buy
01/20/2021 151.92% Raymond James $93 → $108 Maintains Outperform
01/20/2021 144.93% Rosenblatt $100 → $105 Maintains Buy
01/20/2021 172.92% Goldman Sachs $90 → $117 Upgrades Neutral → Buy
12/15/2020 144.93% Morgan Stanley → $105 Upgrades Equal-Weight → Overweight
11/03/2020 114.6% Morgan Stanley $84 → $92 Maintains Equal-Weight
11/03/2020 133.26% Rosenblatt $105 → $100 Maintains Buy
10/13/2020 144.93% Rosenblatt $110 → $105 Maintains Buy
09/18/2020 109.94% Raymond James $98 → $90 Maintains Outperform
09/01/2020 128.6% Stifel $105 → $98 Maintains Buy
08/12/2020 95.94% Morgan Stanley $75 → $84 Maintains Equal-Weight
08/12/2020 165.92% MKM Partners $107 → $114 Maintains Buy
08/12/2020 156.59% Rosenblatt $105 → $110 Maintains Buy
07/23/2020 156.59% Loop Capital → $110 Initiates Coverage On → Buy
05/06/2020 121.6% Jefferies $80 → $95 Maintains Buy
05/06/2020 130.93% B. Riley Securities $96 → $99 Maintains Buy
04/24/2020 121.6% Rosenblatt $100 → $95 Maintains Buy
03/19/2020 74.95% Morgan Stanley $77 → $75 Maintains Equal-Weight
02/05/2020 137.93% Goldman Sachs $77 → $102 Reiterates → Buy
02/05/2020 133.26% Rosenblatt $90 → $100 Maintains Buy
02/04/2020 114.6% Raymond James $88 → $92 Maintains Outperform
01/16/2020 116.93% B. Riley Securities $75 → $93 Maintains Buy
01/10/2020 105.27% Raymond James → $88 Downgrades Strong Buy → Outperform
01/09/2020 98.27% UBS $71 → $85 Downgrades Buy → Neutral
01/02/2020 112.27% MKM Partners $75 → $91 Reiterates → Buy
01/02/2020 109.94% Needham $70 → $90 Downgrades Strong Buy → Buy
12/12/2019 109.94% Susquehanna → $90 Initiates Coverage On → Positive
11/11/2019 51.62% Morgan Stanley $68 → $65 Downgrades Overweight → Equal-Weight
08/09/2019 51.62% Barclays $60 → $65 Maintains Overweight
06/06/2019 16.63% Barclays $60 → $50 Maintains Overweight
03/27/2019 51.62% Morgan Stanley $55 → $65 Upgrades Equal-Weight → Overweight
03/22/2019 51.62% JP Morgan $50 → $65 Upgrades Neutral → Overweight
03/14/2019 81.95% Raymond James $75 → $78 Maintains Strong Buy
01/03/2019 98.27% Raymond James $87 → $85 Maintains Strong Buy
12/11/2018 102.94% Raymond James $88 → $87 Maintains Strong Buy
11/14/2018 23.63% UBS $80 → $53 Maintains Buy
11/13/2018 28.29% Morgan Stanley $66 → $55 Maintains Equal-Weight
11/13/2018 72.61% B. Riley Securities $88 → $74 Maintains Buy
11/13/2018 16.63% JP Morgan $80 → $50 Downgrades Overweight → Neutral

What is the target price for Lumentum Holdings (LITE)?

The latest price target for Lumentum Holdings (NASDAQ: LITE) was reported by Raymond James on November 9, 2023. The analyst firm set a price target for $54.00 expecting LITE to rise to within 12 months (a possible 25.96% upside). 48 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Lumentum Holdings (LITE)?

The latest analyst rating for Lumentum Holdings (NASDAQ: LITE) was provided by Raymond James, and Lumentum Holdings maintained their outperform rating.

When is the next analyst rating going to be posted or updated for Lumentum Holdings (LITE)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumentum Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumentum Holdings was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.

Is the Analyst Rating Lumentum Holdings (LITE) correct?

While ratings are subjective and will change, the latest Lumentum Holdings (LITE) rating was a maintained with a price target of $49.50 to $54.00. The current price Lumentum Holdings (LITE) is trading at is $42.87, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment